跳至主要内容
临床试验/JPRN-UMIN000032442
JPRN-UMIN000032442尚未招募未知

A randomized controlled trial to assess the efficacy and safety of RACOL for adverse events such as stomatitis and malnutrition during adjuvant chemotherapy of gastric cancer patients - A randomized controlled trial to assess the efficacy and safety of RACOL during adjuvant chemotherapy of gastric cancer patients

Gunma University0 个研究点目标入组 60 人开始时间: 2018年6月1日最近更新:
适应症

试验速览

阶段
未知
状态
尚未招募
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 75years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1) Patients with drug allergy of omega-3 faty acid-containing enteral nutrition. 2) patients with severe complications (heart disease, pulumonary fibrosis, interstitial pneumonia, bleeding tendency). 3) Patients with fever or severe infection. 4) Patients with active double cancer. 5) Patients with paralysis, peripheral neuropathy and edema. 6) Patients with active pleural or pericardial effusion. 7) Patients with severe drug allergy. 8) Patients who are pregnant, suspected to be pregnant or breastfeeding. 9) Patients with severe psychiatric disorder. 10) The patient who was considered ineligible by the investigators.

研究者

相似试验